Susquehanna International Group’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,028
| Closed | -$155K | – | 6886 |
|
|
2024
Q1 | $155K | Hold |
59,028
| – | – | ﹤0.01% | 4815 |
|
|
2023
Q4 | $213K | Hold |
59,028
| – | – | ﹤0.01% | 4937 |
|
|
2023
Q3 | $301K | Hold |
59,028
| – | – | ﹤0.01% | 4033 |
|
|
2023
Q2 | $504K | Sell |
59,028
-1
| -0% | -$9 | ﹤0.01% | 3614 |
|
|
2023
Q1 | $696K | Hold |
59,029
| – | – | ﹤0.01% | 3386 |
|
|
2022
Q4 | $850K | Hold |
59,029
| – | – | ﹤0.01% | 2515 |
|
|
2022
Q3 | $2.96M | Hold |
59,029
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q2 | $5.03M | Hold |
59,029
| – | – | ﹤0.01% | 920 |
|
|
2022
Q1 | $8.91M | Hold |
59,029
| – | – | ﹤0.01% | 791 |
|
|
2021
Q4 | $17.7M | Hold |
59,029
| – | – | ﹤0.01% | 507 |
|
|
2021
Q3 | $23M | Buy |
+59,029
| New | +$23M | ﹤0.01% | 427 |
|